Antibiotic resistance developing in Channel Islanders?

The government of Jersey is concerned that the islanders are developing resistance to antibiotics.

Around 250 people get a prescription for an antibiotics in Jersey every day. This represents a prescription rate 25% higher than in England.

The Jersey government is encouraging islanders to be more cautious in taking antibiotics to help prevent resistance developing :

“We can’t stop antibiotic resistance but we can slow it down by preserving the antibiotics we currently have for now and future generations. We need to act fast and together before we enter an era where no antibiotics work.”

SOURCE : Island of Jersey – Antiobiotic Resistance


Last-line antibiotics are failing

The European Centre for Disease Prevention and Control (ECDC) has released its latest EU-wide data on antibiotic resistance and antibiotic consumption.

In 2015, antibiotic resistance continued to increase for most bacteria and antibiotics under surveillance. In particular, the EU average percentage of carbapenem resistance in Klebsiella pneumoniae increased from 6.2% in 2012 to 8.1% in 2015, and combined resistance to carbapenems and polymyxins (eg colistin) was sometimes reported. These two groups of antibiotics are considered last-line antibiotics as they usually are the last treatment options for patients infected with bacteria resistant to other available antibiotics.

While antibiotic consumption in hospitals significantly increased in several EU Member States, antibiotic consumption in the community decreased in six EU Member States.

ECDC’s data also shows that antibiotic resistance in Escherichia coli, one of the most frequent causes of bloodstream infections and urinary tract infections, requires close attention as the percentages of isolates resistant to commonly used antibiotics continues to increase throughout Europe.

In contrast, the percentage of meticillin-resistant Staphylococcus aureus (MRSA) showed a significantly decreasing trend at EU/EEA level between 2012 and 2015. Despite this positive development, MRSA remains a public health priority as eight out of thirty countries reported percentages above 25%.


DATE : 18 November 2016

SOURCE : European Centre for Disease Prevention and Control